A groundbreaking study has identified a novel mechanism by which a single small molecule can leverage two distinct cellular pathways…
Read More
Breakthrough Discovery by McGill Researchers Identifies Cellular Disruptions in the Depressed Brain Paving the Way for Targeted Therapies
In a landmark study that bridges the gap between molecular genetics and clinical psychiatry, researchers at McGill University and the…
Read More
Sai Life Sciences Hosts Landmark Biotech Pitch Day 2026, Spotlighting Innovative Early-Stage Therapies and Fostering Strategic Collaborations
Sai Life Sciences, a leading global contract research, development, and manufacturing organization (CRDMO), recently convened its highly anticipated Biotech Pitch…
Read More
The Dawn of In Vivo Cell Therapies: A New Era in Precision Medicine Unfolds Amidst Significant Investment and Innovation
The pharmaceutical landscape is witnessing a profound transformation with the ascendance of in vivo cell therapies, a revolutionary approach that…
Read More
US Food and Drug Administration Unveils Draft Guidance for Genome Editing Therapies, Prioritizing Safety Through Next-Generation Sequencing
The US Food and Drug Administration (FDA) has issued draft guidance aimed at enhancing the safety assessment of genome editing…
Read More
AACR 2026 Annual Meeting in San Diego to Highlight Precision Oncology and Integrated Therapies Under Co-Chairs Alice Shaw and Paul Mischel
The global scientific community is counting down the days until the highly anticipated 2026 annual meeting of the American Association…
Read More
Bristol Myers Squibb and Oxford BioTherapeutics Forge Alliance to Pioneer Novel T-Cell Engager Therapies for Solid Tumors
Bristol Myers Squibb (BMS) and Oxford BioTherapeutics (OBT) have announced a significant strategic alliance aimed at discovering and developing a…
Read More
Roche and C4 Therapeutics Forge Strategic Alliance to Pioneer Degrader-Antibody Conjugates for Novel Cancer Therapies
Roche and C4 Therapeutics Forge Strategic Alliance to Pioneer Degrader-Antibody Conjugates for Novel Cancer Therapies Roche, a global pharmaceutical giant,…
Read More
Emerging therapies bring hope for frail HNSCC patients unfit for standard treatment – Pharmaceutical Technology
The global burden of head and neck squamous cell carcinoma (HNSCC) is on an upward trajectory, with an estimated increase…
Read More
RoosterBio and MineBio Forge Exclusive Partnership to Accelerate MSC and Exosome Therapies in China
RoosterBio, a prominent innovator in the field of mesenchymal stem cell (MSC) and exosome bioprocessing, has announced an exclusive distributor…
Read MoreYOU MAY HAVE MISSED
